Showing 1 - 10 of 10,421
Harm reduction interventions to reduce blood-borne disease incidence among injection drug users (IDUs). A common strategy to estimate the long-term impact of such interventions is to examine short-term incidence changes within a specific group of individuals exposed to the intervention. Such...
Persistent link: https://www.econbiz.de/10009476725
Persistent link: https://www.econbiz.de/10011542909
Persistent link: https://www.econbiz.de/10010252982
Persistent link: https://www.econbiz.de/10011896631
Background: The impact of compliance to clinical practice guidelines (CPG) on outcomes and/or costs of care has not been completely clarified.Objective: To estimate relationships between medical expenditures and compliance to CPG for initial sarcoma treatment.Research design: Selected cohorts of...
Persistent link: https://www.econbiz.de/10008792742
Advertising plays a major role in differentiating brands. Many advertisements attempt to create positive feelings through the use of humor, music, or attractive spokespersons. Marketers hope the positive emotions (i.e., positive affect) evoked by these types of ads will transfer to the...
Persistent link: https://www.econbiz.de/10009430399
The growth of Internet technology and electronic commerce has not been matched by theoretically-guided social science research. Well-developed consumer research is needed to illustrate the nature and possible scope of the Internet retail choice in the marketplace. The primary purpose of this...
Persistent link: https://www.econbiz.de/10009430606
them in using social networks to citizenship missions in oncology. …
Persistent link: https://www.econbiz.de/10012047075
In order to develop better treatment and screening programs for cancer prevention programs, it is important to be able to understand the natural history of the disease and what factors affect its progression. We focus on a particular framework first outlined by Kimmel and Flehinger (1991,...
Persistent link: https://www.econbiz.de/10009477554
, focusing on overall survival as the preferred endpoint in oncology. A taskforce of experienced German outcomes research … external stakeholders. Distinctive features of registration trials in oncology need to be considered when these studies form … clinical trial programs that were developed to be consistent with regulatory guidance, endpoints in oncology are thoroughly …
Persistent link: https://www.econbiz.de/10011599811